ArticleCancer medicine2023

Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey.

Daniel J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.